CLINICAL_TRIALS
trial_result
· 2022-10-18
Clinical Trial Update: High Intensity Lipid Lowering Following Acute Coronary Syndromes for Persons Living With HIV [Phase 2]
Summary
A Phase 2 clinical trial evaluated high intensity lipid lowering in people living with HIV after acute coronary syndromes; status completed with results posted …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Matthew Feinstein | Conditions: HIV Infection, Coronary Heart Disease | Phase 2 | Status: COMPLETED | Results posted: 2022-10-18